Latest News and Press Releases

-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case...

MIAMI, FL, June 11, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”) today announced a debt-to-equity conversion that reduces leverage and strengthens its...

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- DoubleVerify ("DV") (NYSE: DV), the leading software platform to verify media quality, optimize advertising performance and prove campaign outcomes, today...

Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities across Its Cirrus Vision Jet Fleet Creates Additional Distribution Channel for Flyte...

ZenaTech Signs Offer to Acquire a Western Canadian Geospatial and Land Surveying Company to Accelerate Drone as a Service in Utilities, Forestry, Agricultu

TEPHRA™ platform selected to support next-generation photonic device production, further expanding Forge Nano's presence in the growing photonics manufacturing market DENVER, June 11, 2026 (GLOBE...

3E Network partnered with Aladdin Alaris AI to jointly develop healthcare and eldercare robots, carry out technical cooperation and expand the U.S. market

PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease Grant supports extension of Part 1 of Phase 2 VacSYn trial of ACI-7104Planned extension of...

OPTAVIA's RCT used DXA scanning and a 92.3% completion rate to document 98% lean mass retained in 198 participants across 16 weeks.